SECONDARY SOLID TUMORS IN CHILDREN AFTER ALLOGENEIC HEMATOPOIETIC STEM CELLS TRANSPLANTATION: CASE REPORTS AND LITERATURE REVIEW
https://doi.org/10.17650/1818-8346-2017-12-2-39-53
Abstract
Allogeneic hematopoietic stem cell transplantation (HSCT) is an effective approach to cure numerous malignant and nonmalignant diseases. This method is more available now, respectively the number of survivors – recipients of HSCT increases every year. Among long-term complications of HSCT secondary solid cancers are one of the most life-threatening. We discuss different types of secondary solid tumours after HSCT and describe international recommendations of their screening and diagnostic. Several case reports from the single center could illustrate these serious late effects.
About the Authors
Yu. V. Skvortsova
National Scientific and Practical Center of Pediatric Hematology, Oncology and Immunology named after Dmitry Rogachev
Russian Federation
1, Samory Mashela Str., Moscow, 117997
Russian Federation
1, Samory Mashela Str., Moscow, 117997
D. N. Balashov
National Scientific and Practical Center of Pediatric Hematology, Oncology and Immunology named after Dmitry Rogachev
Russian Federation
1, Samory Mashela Str., Moscow, 117997
Russian Federation
1, Samory Mashela Str., Moscow, 117997
L. N. Shelichova
National Scientific and Practical Center of Pediatric Hematology, Oncology and Immunology named after Dmitry Rogachev
Russian Federation
1, Samory Mashela Str., Moscow, 117997
Russian Federation
1, Samory Mashela Str., Moscow, 117997
A. E. Rudneva
National Scientific and Practical Center of Pediatric Hematology, Oncology and Immunology named after Dmitry Rogachev
Russian Federation
Russian Federation
M. A. Maschan
National Scientific and Practical Center of Pediatric Hematology, Oncology and Immunology named after Dmitry Rogachev
Russian Federation
1, Samory Mashela Str., Moscow, 117997
Russian Federation
1, Samory Mashela Str., Moscow, 117997
G. V. Tereshchenko
National Scientific and Practical Center of Pediatric Hematology, Oncology and Immunology named after Dmitry Rogachev
Russian Federation
1, Samory Mashela Str., Moscow, 117997
Russian Federation
1, Samory Mashela Str., Moscow, 117997
E. V. Skorobogatova
Russian Children Clinical Hospital
Russian Federation
117, Leninskiy Prospect, Moscow, 119571
Russian Federation
117, Leninskiy Prospect, Moscow, 119571
I. V. Kondratenko
Russian Children Clinical Hospital
Russian Federation
117, Leninskiy Prospect, Moscow, 119571
Russian Federation
117, Leninskiy Prospect, Moscow, 119571
S. S. Vachlyarskaya
Russian Children Clinical Hospital
Russian Federation
117, Leninskiy Prospect, Moscow, 119571
Russian Federation
117, Leninskiy Prospect, Moscow, 119571
I. D. Borodina
National Scientific and Practical Center of Pediatric Hematology, Oncology and Immunology named after Dmitry Rogachev
Russian Federation
1, Samory Mashela Str., Moscow, 117997
Russian Federation
1, Samory Mashela Str., Moscow, 117997
A. A. Bologov
Russian Children Clinical Hospital
Russian Federation
117, Leninskiy Prospect, Moscow, 119571
Russian Federation
117, Leninskiy Prospect, Moscow, 119571
A. G. Rumyantsev
National Scientific and Practical Center of Pediatric Hematology, Oncology and Immunology named after Dmitry Rogachev
Russian Federation
1, Samory Mashela Str., Moscow, 117997
Russian Federation
1, Samory Mashela Str., Moscow, 117997
E. V. Samochatova
National Scientific and Practical Center of Pediatric Hematology, Oncology and Immunology named after Dmitry Rogachev
Russian Federation
1, Samory Mashela Str., Moscow, 117997
Russian Federation
1, Samory Mashela Str., Moscow, 117997
A. A. Maschan
National Scientific and Practical Center of Pediatric Hematology, Oncology and Immunology named after Dmitry Rogachev
Russian Federation
1, Samory Mashela Str., Moscow, 117997
Russian Federation
1, Samory Mashela Str., Moscow, 117997
References
1. Inamoto Y., Shah N.N., Savani B.N. et al. Secondary solid cancer screening following hematopoietic cell transplantation. Bone Marrow Transplant 2015,50(8):1013–23. DOI: 10.1038/bmt.2015.63.
2. Inamoto Y., Lee S.J. Late effects of blood and marrow transplantation. Haematologica 2017,102(4):614–25. DOI: 10.3324/haematol.2016.150250. PMID: 28232372.
3. Tichelli A., Rovo A. Long-term outcome after hematopoietic stem cell transplant in patients with aplastic anemia. Curr Drug Targets 2016,22. [Epub ahead of print]. PMID: 27339193.
4. Ehrhardt M.J., Brazauskas R., He W. et al. Survival of patients who develop solid tumors following hematopoietic stem cell transplantation. Bone Marrow Transplant 2016,51(1):83–8. DOI: 10.1038/bmt.2015.203. PMID: 26367222.
5. Stewart B.W., Wild C.P. et al. World Health Organisation. 1st edition. International Agency for Research in cancer (IARC). 2014.
6. Curtis R.E., Metayer C., Rizzo J.D. et al. Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem cell transplantation: an international casecontrol study. Blood 2005,105:3802–11. DOI: 10.1182/blood-2004-09-3411. PMID: 15687239.
7. Rizzo J.D., Curtis R.E., Socié G. et al. Solid cancers after allogeneic stem cell transplantation. Blood 2009,113:1175–83. DOI: 10.1182/blood-2008-05-158782. PMID: 18971419.
8. Atsuta Y., Suzuki R., Yamashita T. et al. Continuing increased risk of oral/esophageal cancer after allogeneic hematopoietic stem cell transplantation in adults in association with chronic graft-versus-host disease. Ann Oncol 2014,25:435–41. DOI: 10.1093/annonc/mdt558. PMID: 24399081.
9. Leisering W., Friedman D.L., Flowers M.E. et al. Nonmelanoma skin and mucosal cancers after hematopoietic stem cell transplantation. J Clin Oncol 2006,24:1119–26. DOI: 10.1200/JCO.2005.02.7052. PMID: 16461782.
10. Williams K., Mansh M., Chin-Hong P. et al. Voriconazole-associated cutaneous malignancy: a literature review on photocancerogenesis in organ transplant recipients. Clin Inf Diseases 2014,58:997–1002. DOI: 10.1111/ajt.13431. PMID: 26372838.
11. Green A., Williams G., Neale R. et al. Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomized control trial. Lancet 1999,354:723–9. DOI: 10.1016/S0140-6736(98)12168-2. PMID: 18751308.
12. Lau S.C., Chen L., Cheung W.Y. Protective skin care behaviors in cancer survivors. Curr Oncol 2014,21:e531-e40. DOI: 10.3747/co.21.1893. PMID: 25089104.
13. Baker K.S., DeFor T.E., Burns L.J. et al. New malignancies after blood or marrow stem-cell transplantation in children and adults: incidence and risk factors. J Clin Oncol 2003,21:1352–8. DOI: 10.1200/JCO.2003.05.108. PMID: 12663726
14. Cohen A., Rovelli A., Merlo D.F. et al. Risk for secondary thyroid carcinoma after hematopoietic stem – cell transplantation: an EBMT Late Effects Working Party Study. J Clin Oncol 2007,25:2449–54. DOI: 10.1200/JCO.2006.08.9276. PMID: 17557958.
15. Ringden O., Brazauskas R., Wang Z. et al. Second solid cancers after allogeneic hematopoietic cell transplantation using reduced-intensity conditioning. Biol Blood Marrow Transplant 2014,20:1777–84. DOI: 10.1016/j.bbmt.2014.07.009. PMID: 25042734.
16. Curtis R.E., Metayer C., Rizzo J.D. et al. Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem cell transplantation: an international casecontrol study. Blood 2005,105:3802–11. DOI: 10.1182/blood-2004-09-3411. PMID: 15687239.
17. Danner-Koptik K.E., Majhail N.S., Brazauskas R. et al. Second malignancies after autologous hematopoietic cell transplantation in children. Bone Marrow Transplant 2013,48:363–8. DOI: 10.1038/bmt.2012.166. PMID: 22964594.
18. Bhatia S., Louie A.D., Bhatia R. et al. Solid cancers after bone marrow transplantation. J Clin Oncol 2001,19:464–71. DOI: 10.1200/JCO.2001.19.2.464. PMID: 11208840.
19. Ruccione K.S., Wood J.C., Sposto R. et al. Characterization of transfusion-derived iron deposition in childhood cancer survivors. Cancer Epidemiol Biomarkers Prev 2014,23:1913–9. DOI: 10.1158/1055-9965.EPI-14-0292. PMID: 24962841.
20. Rascon J., Rageliene L., Stankeviciene S. et al. An assessment of iron overload in children treated for cancer and non-malignant hematologic disorders. Eur J Pediatr 2014,173:1137–46. DOI: 10.1007/s00431-014-2295-5. PMID: 24659311.
21. Friedman D.L., Rovo A., Leisenring W. et al. Increased risk of breast cancer among survivors of allogeneic hematopoietic cell transplantation: a report from FHCRC and the EBMT-Late Effect Working Party. Blood 2008,111:939–44. DOI: 10.1182/blood-2007-07-099283. PMID: 17911386.
22. Majhail N.S., Brazauskas R., Rizzo J.D. et al. Secondary solid cancers after allogeneic hematopoietic transplantation using busulfan-cyclophosphamide conditioning. Blood 2011,117:316–22. DOI: 10.1182/blood-2010-07-294629. PMID: 20926773.
23. Majhail N.S., Rizzo J.D., Lee S.J. et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Biol Blood Marrow Transplant 2012,18:348–71. DOI: 10.1016/j.bbmt.2011.12.519. PMID: 22178693.
24. Wilck M.B.,Baden L.R. Vaccination after stem cell transplant: a reviewofrecent developments and implicationsfor current practice. Curr Opin Infect Dis 2008,21(4):399–408. DOI: 10.1097/QCO.0b013e328307c7c5. PMID: 18594293.
25. Tedeschi S.K., Savani B.N., Jagasia M. et al. Time to consider HPV vaccination after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2010,16(8):1033–6. DOI: 10.1016/j.bbmt.2010.03.007. PMID: 20302962.
26. Mannuel H.D., Mitikiri N., Hussain A. Update on testicular germ cell tumors. Curr Opin Oncol 2011,23(3):265–70. DOI: 10.1097/CCO.0b013e32834579f0. PMID: 21415748.
27. SchmiegelowK.,LevinsenM.F.,AttarbaschiA. et al. Second malignant neoplasms aftertreatment of childhood acute lymphoblastic leukemia. J Clin Oncol 2013,31(19):2469–76. DOI: 10.1200/JCO.2012.47.0500. PMID: 23690411.
Review
For citations:
Skvortsova Yu.V., Balashov D.N., Shelichova L.N., Rudneva A.E., Maschan M.A., Tereshchenko G.V., Skorobogatova E.V., Kondratenko I.V., Vachlyarskaya S.S., Borodina I.D., Bologov A.A., Rumyantsev A.G., Samochatova E.V., Maschan A.A. SECONDARY SOLID TUMORS IN CHILDREN AFTER ALLOGENEIC HEMATOPOIETIC STEM CELLS TRANSPLANTATION: CASE REPORTS AND LITERATURE REVIEW. Oncohematology. 2017;12(2):39-53. (In Russ.) https://doi.org/10.17650/1818-8346-2017-12-2-39-53
Views:
9583
Email this article 